CANNABIS SUISSE CORP.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5K | $30.0K | $10.0K | $7.8K | $50.9K | $242.7K | $7.5K | $6.5K |
| Cost of Revenue | $22.1K | $30.1K | $9.2K | $1.7K | $36.9K | $182.7K | $2.5K | $2.3K |
| Gross Profit | $432 | $-67 | $834 | $6.0K | $-51.8K | $-84.8K | $5.0K | $4.2K |
| Gross Margin | 1.9% | -0.2% | 8.3% | 77.7% | -101.9% | -34.9% | 66.3% | 64.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $228.7K | $174.7K | $60.7K | $135.6K | $257.4K | $174.4K | $4.3K | $1.6K |
| Operating Income | $-288.0K | $-256.9K | $-342.7K | $-157.2K | $-358.5K | $-351.3K | $-22.7K | $-16.4K |
| Operating Margin | -1,280.1% | -856.5% | -3,426.8% | -2,022.6% | -704.9% | -144.7% | -301.8% | -252.6% |
| Interest Expense | $63.2K | $26.8K | $8.9K | $63.6K | $60.3K | — | — | — |
| Pretax Income | $-456.1K | $-1.2M | $-351.5K | $-187.9K | $-410.9K | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Net Income | $-456.1K | $-1.2M | $-351.5K | $-187.9K | $-410.9K | $-389.2K | $-22.7K | $-16.4K |
| Net Margin | -2,027.3% | -3,955.4% | -3,515.5% | -2,418.1% | -808.1% | -160.3% | -301.8% | -252.6% |
| EPS (Basic) | $-0.01 | $-0.03 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | — | — | — | — | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 70.7M | 47.3M | 42.0M | 33.1M | 34.5M | — | — | — |
| Shares Outstanding (Diluted) | 70.7M | 47.3M | 42.0M | 33.1M | 34.5M | 35.5M | 52.0M | 57.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |